News from thesan pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 25, 2014, 09:00 ET

Thesan Pharmaceuticals Appoints Dr. Bhaskar Chaudhuri to the Board of Directors August 2014

Thesan Pharmaceuticals announced today the appointment of Bhaskar Chaudhuri Ph.D., to its Board of Directors. Dr. Chaudhuri has more than 25 years...

Aug 25, 2014, 09:00 ET

Thesan Pharmaceuticals udpeger Dr. Bhaskar Chaudhuri til bestyrelsen i august 2014

Thesan Pharmaceuticals meddelte i dag, at firmaet udpeger Bhaskar Chaudhuri Ph.D. til bestyrelsen. Dr. Chaudhuri har mere end 25 års erfaring...

Feb 24, 2014, 09:00 ET

Thesan Pharmaceuticals meddeler en finansieringsrunde med B-aktier til en værdi af 49 mio. dollars for februar 2014

Thesan Pharmaceuticals meddelte i dag afslutningen på en finansieringsrunde med B-aktier til en værdi af 49 mio. dollars, der ledes af...

Feb 24, 2014, 09:00 ET

Thesan Pharmaceuticals Announces a $49M Series B Financing February 2014

 Thesan Pharmaceuticals announced today the closing of a $49M Series B financing, led by Novo Ventures (a current Investor), with SV Life...

Oct 31, 2012, 14:44 ET

Thesan Pharmaceuticals offentliggør første runde af venturefinansieringen ledt af Novo Ventures og Novartis Venture Funds i fællesskab

Thesan Pharmaceuticals offentliggjorde afslutningen på første runde af en 16 millioner dollars venturefinansiering ledt af Novo Ventures...

Oct 31, 2012, 14:35 ET

Thesan Pharmaceuticals annuncia un finanziamento di serie A co-gestito da Novo Ventures e Novartis Venture Funds

 Thesan Pharmaceuticals annuncia la chiusura di un finanziamento di serie A di 16 milioni di dollari, co-gestito da Novo Ventures e Novartis...

Oct 31, 2012, 03:56 ET

Thesan Pharmaceuticals annonce un financement de série A codirigé par Novo Ventures et Novartis Venture Funds

 Thesan Pharmaceuticals a annoncé la clôture d'un financement de série A de 16 millions $, codirigé par Novo...

Oct 30, 2012, 21:24 ET

Thesan Pharmaceuticals gibt Serie-A-Finanzierung unter gemeinsamer Führung von Novo Ventures und Novartis Venture Funds bekannt

Thesan Pharmaceuticals gab den Abschluss einer Serie-A-Finanzierung in Höhe von 16 Millionen $ bekannt, welche von Novo Ventures und Novartis...

Oct 30, 2012, 11:58 ET

Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds

 Thesan Pharmaceuticals announced the closing of a $16M Series A financing, co-led by Novo Ventures and Novartis Venture Funds.  The...